Calpain Cleaves Tumor Suppressors NORE1A and RASSF1A
Author Information
Author(s): Kuznetsov Sergey, Khokhlatchev Andrei V.
Hypothesis
Calpains mediate the proteolysis of NORE1A and RASSF1A, leading to their downregulation in cancer cells.
Conclusion
Calpain-mediated degradation is a novel mechanism for the downregulation of NORE1A and RASSF1A proteins, potentially allowing cancer cells to evade growth suppression.
Supporting Evidence
- NORE1A and RASSF1A are downregulated in various cancers.
- Calpain inhibitors restored NORE1A expression in cancer cell lines.
- Three out of ten human lung tumors showed activity that induced NORE1A degradation.
Takeaway
Some proteins that help stop cancer growth can be broken down by certain enzymes, which might help cancer cells grow more easily.
Methodology
The study involved proteolysis experiments using extracts from human lung cancer cell lines and tumor samples to assess the degradation of NORE1A and RASSF1A.
Limitations
The study primarily focused on specific cancer cell lines and may not represent all cancer types.
Participant Demographics
The study included extracts from human lung tumors and cell lines derived from lung cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website